This series brings to the reader a comprehensive view of the current global scenario of the pharma industry. India and China are big markets, after the US and Europe. Vol. I includes five articles on the US, Europe, India and China and a perspective on Asia. Case studies on Pfizer, GlaxoSmithKline, Ranbaxy and Cipla also feature here.
Vol. III explores new business designs, collaborative efforts, reduced dependence on the blockbuster model for sustenance, customer-centric approach, focus on niche therapeutic areas, and interdisciplinary studies and research, are some drivers to the pharma industry. This book includes articles from globally reputed consulting firms and five case studies of top global and Indian pharma companies.
Vol. II discusses the impact of innovation, technology and globalization that has also opened up new resources and opportunities. It has eight interesting articles that deal with marketing innovations, wireless applications, evaluation of marketing and sales capabilities and e-health, apart from interesting case studies.
This book examines Pension systems in the context of global economic recession, demographic changes, the security of the ageing society and other issues. It begins with global experiences like that of US, Latin America and Germany and moves to contemporary issues and pension systems in India as well as Pension Fund Management and future trends.